N-Style ID Medical Jewelry

n-style id bracelets

N-Style ID was founded by Toni Bissell, an independent, creative powerhouse and a single mother of two teenage daughters who has an extensive background in health and fitness. She was working as a personal trainer at a Lake Tahoe gym when a sudden illness transformed her family forever.

Her then-10-year-old daughter, Camille, after a frightening week-long stay in the hospital, was diagnosed with Type I Diabetes. Toni's family focus, already health centered, became even more so. Camille and her mother worked to establish new patterns of eating; they learned how to administer insulin injections and how to check blood sugar many times a day. The impossible task was to find a medical ID a fashion-conscious young woman would wear.

It didn't take Toni long to realize that she was being called to help her daughter and others find medical ID's that were fun to wear. Hence, N-Style ID was born.

Toni's vision is to make the lives of all those dealing with conditions requiring a medical ID less stressful by providing fun and fashionable medical jewelry. As strong advocates for Organ Donation, Toni and her other daughter, Haley, also wear their own collection of N-Style ID's™ which simply say, "ORGAN DONOR."

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap